Skip to main content

Table 1 Comparison of baseline clinical and computed tomography angiography characteristics at patient level

From: Serum marker and CT characteristics of coronary calcified nodule assessed by intravascular ultrasound

 

Whole Cohort

(n = 79)

Calcified nodule

(n = 9)

Non-nodular calcification

(n = 70)

P value

Age (year)

61.76 ± 11.53

62.11 ± 13.39

61.71 ± 11.38

0.923

 ≥ 70 year (%)

21 (26.58)

3 (33.33)

18 (25.71)

0.693

Men (%)

62 (78.48)

8 (88.89)

54 (77.14)

0.675

Body mass index (kg/m2)

24.94 (23.66, 26.47)

24.94 (23.34, 26.44)

24.94 (23.66, 26.53)

0.609

Current smoking (%)

17 (21.52)

1 (11.11)

16 (22.86)

0.675

Diabetes (%)

28 (35.44)

3 (33.33)

25 (35.71)

1.00

Hypertension (%)

58 (73.42)

7 (77.78)

51 (72.86)

1.00

Dyslipidemia (%)

79 (100.00)

9 (100.00)

70 (100.00)

NC

Prior myocardial infarction (%)

17 (21.52)

2 (22.22)

15 (21.43)

1.00

Prior PCI (%)

16 (20.25)

2 (22.22)

14 (20.00)

1.00

Chronic kidney disease (%)

6 (7.59)

0 (0)

6 (8.57)

1.00

Family history of premature CAD (%)

6 (7.59)

0 (0)

6 (8.57)

1.00

Clinical presentation

 Stable angina pectoris (%)

15 (18.99)

4 (44.44)

11 (15.71)

0.061

 Acute coronary syndrome (%)

64 (81.01)

5 (55.56)

59 (84.29)

0.061

Total cholesterol (mmol/L)

3.47 (2.94, 4.26)

3.17 (2.65, 3.79)

3.58 (2.94, 4.32)

0.257

HDL-C (mmol/L)

0.90 (0.77, 1.01)

0.81 (0.76,0.92)

0.91 (0.79, 1.01)

0.396

LDL-C (mmol/L)

2.03 (1.51, 2.57)

1.83 (1.34, 2.28)

2.04 (1.50, 2.70)

0.280

Triglyceride (mmol/L)

1.35 (0.97, 1.81)

1.12 (0.68, 1.57)

1.43 (1.01, 2.01)

0.063

Hemoglobin A1C (%)

6.00 (5.60, 6.90)

6.00 (5.40, 6.58)

6.10 (5.60, 7.00)

0.482

Fasting blood glucose (mmol/L)

5.60 (4.91, 7.06)

5.08 (4.19, 6.28)

5.60 (5.06, 7.18)

0.263

GFR (ml/min/1.73m2)

106.21 (87.48, 124.13)

111.06 (87.41, 123.16)

106.13 (88.40, 124.42)

0.853

Peak hs-cTnT (ng/mL)

0.011 (0.006, 0.057)

0.008 (0.0045, 0.0805)

0.011 (0.006, 0.0595)

0.671

Peak pro-BNP (pg/mL)

124.30 (50.22, 637.90)

100.80 (44.48, 240.00)

126.65 (51.93, 728.75)

0.388

hs-CRP (mg/L)

2.85 (1.15, 2.85)

1.31 (0.62, 6.43)

2.85 (1.17, 2.85)

0.634

Alkaline phosphatase (U/L)

69.00 (52.00, 87.00)

82.00 (54.50, 93.50)

65.00 (42.00, 77.50)

0.022

Gamma-glutamyltransferas (U/L)

26.00 (17.00,37.00)

25.00 (18.00, 43.50)

26.00 (16.75, 37.00)

0.920

Serum calcium (mmol/L)

2.25 ± 0.15

2.21 ± 0.14

2.26 ± 0.15

0.336

Left ventricular ejection fraction (%)

67.00 (61.00, 71.00)

70.00 (62.50, 75.00)

67.00 (61.00, 71.00)

0.256

Multi-vessel disease (%)

52 (65.82)

6 (66.67)

46 (65.71)

0.325

Total plaque volume (mm3)

490.00 (151.00, 969.00)

673.00 (256.50, 1516.05)

467.50 (150.50, 940.75)

0.021

Lipid volume (mm3)

89.90 (40.40, 163.40)

119.30 (48.65, 229.90)

80.50 (40.23, 161.15)

0.468

Fiber volume (mm3)

122.80 (54.10, 208.60)

205.10 (64.40, 282.60)

122.25 (53.70, 201.43)

0.347

Calcification volume (mm3)

236.60 (52.90, 585.80)

468.50 (144.75, 1029.40)

197.30 (49.38, 582.48)

0.165

Lipid percentage (%)

20.64 (15.97, 27.25)

17.12 (12.44, 21.55)

20.71 (16.25, 29.09)

0.073

Fiber percentage (%)

25.22 (20.39, 39.91)

22.42 (15.65, 31.06)

25.64 (20.50, 40.53)

0.235

Calcification percentage (%)

54.91(41.48, 64.20)

60.36 (47.77, 71.20)

54.58 (39.99, 63.68)

0.156

  1. Normally distributed continuous variables were expressed as mean ± SD, non-normal distribution as median with interquartile range (IQR), and categorical variables as numbers and percentages
  2. Abbreviations: CAD coronary heart disease, GFR glomerular filtration rate, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, LDL-C low-density lipoprotein cholesterol, LVEF left ventricular ejection fraction, PCI percutaneous coronary intervention, pro-BNP pro-brain natriuretic peptide